|
hepatocellular carcinoma |
22 |
|
hcc |
17 |
|
medical sciences |
14 |
|
liver transplant |
13 |
|
cirrhosis |
11 |
|
gastroenterology medical sciences |
11 |
|
high-intensity focused ultrasound |
11 |
|
surgery |
11 |
|
ablation |
10 |
|
bridging therapy |
10 |
|
liver cancer |
10 |
|
molecular biology |
10 |
|
molecular pathology |
10 |
|
new technology |
10 |
|
signaling |
10 |
|
nafld |
9 |
|
nash |
9 |
|
non-viral liver disease |
9 |
|
tumorigenesis |
9 |
|
metastasis |
8 |
|
transarterial chemoembolization |
8 |
|
waiting list |
8 |
|
liver cirrhosis |
7 |
|
liver transplantation |
7 |
|
prognosis |
7 |
|
biomarker |
6 |
|
carcinoma, hepatocellular - blood - metabolism |
6 |
|
cell line, tumor |
6 |
|
dkk1 |
6 |
|
gastroenterology |
6 |
|
intercellular signaling peptides and proteins - blood - metabolism |
6 |
|
jnk |
6 |
|
liver neoplasms - blood - metabolism |
6 |
|
non-alcoholic fatty liver disease |
6 |
|
nuclear factor kappa b |
6 |
|
nuclear met |
6 |
|
stc1 |
6 |
|
transforming growth factor beta-activated kinase 1 |
6 |
|
tumor markers, biological - blood - metabolism |
6 |
|
wnt |
6 |
|
arginase |
5 |
|
arginine deiminase |
5 |
|
arginine metabolism |
5 |
|
bacterial pathogenesis |
5 |
|
cancer therapy |
5 |
|
dyslipidemia |
5 |
|
hepatitis b |
5 |
|
hepatoblastoma |
5 |
|
herbal medicine |
5 |
|
liver steatosis |
5 |
|
obese mice |
5 |
|
pediatric |
5 |
|
pretreatment extent of disease |
5 |
|
relapse |
5 |
|
risk stratification |
5 |
|
biliary anastomotic stricture |
4 |
|
clonorchis sinensis |
4 |
|
deceased-donor liver transplantation |
4 |
|
dna methylation |
4 |
|
dna methylation - immunology |
4 |
|
e-cadherin |
4 |
|
er stress |
4 |
|
gastric cancer |
4 |
|
gastritis/genetics - immunology/prevention & control |
4 |
|
gata |
4 |
|
helicobacter infections/genetics - immunology/microbiology |
4 |
|
helicobacter pylori |
4 |
|
inflammation |
4 |
|
inhibitor |
4 |
|
interleukin-1b |
4 |
|
interleukin-1beta/genetics - immunology/metabolism |
4 |
|
nitric oxide |
4 |
|
pim kinase |
4 |
|
receptors, interleukin-1 type i/genetics - immunology/metabolism |
4 |
|
reprogramming |
4 |
|
scd1 |
4 |
|
sorafenib |
4 |
|
t-ics |
4 |
|
tace |
4 |
|
therapeutics |
4 |
|
allograft |
3 |
|
cancer stem cells |
3 |
|
cdk1 |
3 |
|
cholestasis |
3 |
|
heterogeneity |
3 |
|
immunohistochemistry |
3 |
|
molecular alterations |
3 |
|
multifocal hcc |
3 |
|
next-generation sequencing |
3 |
|
npm |
3 |
|
pim1 |
3 |
|
sox9 |
3 |
|
stemness |
3 |
|
tumor-initiating cells |
3 |
|
acute cellular rejection |
2 |
|
autoimmune |
2 |
|
classification |
2 |
|
female |
2 |
|
gonadoblastoma gene |
2 |
|
hepatic progenitor cell |
2 |
|
hepatic progenitor cells |
2 |
|
hepatocarcinogenesis |
2 |
|
hepatocellular tumors |
2 |
|
humans |
2 |
|
igg4 |
2 |
|
immunohistochemical |
2 |
|
liver |
2 |
|
lung diseases, interstitial - etiology - pathology |
2 |
|
middle aged |
2 |
|
multiple myeloma - complications - diagnosis - physiopathology |
2 |
|
pachymeningitis |
2 |
|
sex chromosomes |
2 |
|
sexual dimorphism |
2 |
|
tspx |
2 |
|
adult |
1 |
|
aged |
1 |
|
biopsy |
1 |
|
biopsy, fine-needle |
1 |
|
breast |
1 |
|
breast neoplasms - diagnosis - pathology |
1 |
|
carcinoma, papillary - diagnosis - pathology |
1 |
|
cd8 |
1 |
|
cell aggregation |
1 |
|
cytology |
1 |
|
diagnosis |
1 |
|
drug-resistance |
1 |
|
epithelial cells - pathology |
1 |
|
epithelioid angiomyolipoma |
1 |
|
fine needle aspiration |
1 |
|
frizzled receptors |
1 |
|
g protein-coupled receptors |
1 |
|
hemangiopericytoma |
1 |
|
hepatic repair complex |
1 |
|
hepatitis-b-virus |
1 |
|
hepatocellular-carcinoma |
1 |
|
histology |
1 |
|
immuno - histochemistry |
1 |
|
invasive micropapillary carcinoma |
1 |
|
liver fibrosis |
1 |
|
metastatic carcinoma |
1 |
|
mutation |
1 |
|
mutations |
1 |
|
neoplasm invasiveness |
1 |
|
phenotype |
1 |
|
regression |
1 |
|
retrospective studies |
1 |
|
tregs |
1 |
|
wnt signaling |
1 |
|
x protein |
1 |
|
young-onset |
1 |
|
β-catenin |
1 |
